U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Advisory Committee on Immunization Practices (ACIP)

CDC Stacks Public Health Publications

The ACIP is a group of medical and public health experts that develops recommendations on the use of vaccines in the civilian population of the United States. The ACIP holds three meetings each year at the Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia to make vaccine recommendations. Meetings are open to the public and available online via webcast. More information on ACIP is available at: https://www.cdc.gov/vaccines/acip/index.html.

(93)
(133)
(235)
(276)
(178)
(127)
(140)
(113)
(96)
(83)
(115)
(117)
(125)
(16)
(24)
(16)
(19)
(13)
(17)
(9)
(8)
(15)
(11)
(6)
(10)
(10)
(5)
(10)
(11)
(5)
(8)
(9)
(6)
(9)
(8)
(7)
(6)
(10)
(5)
(6)
(5)
(6)
(6)
(5)
(5)
(6)
(9)
(3)
(8)
(4)
(3)
(2)
(5)
(3)
(2)
(4)
(3)
(3)
(2)
(2)
(1)
0 of 61
(11)
(32)
(1)
(1)
(122)
(197)
(11)
(1)
(10)
(56)
(1)
(52)
(49)
(9)
(1293)
(1)
(303)
(7)
0 of 18
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(448)
(1)
(1)
(1)
(1)
0 of 36
(1)
0 of 1
(10)
(5)
(1)
(4)
(2)
(1)
(1)
(4)
(1)
(5)
(3)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(139)
(1)
(159)
(1)
(33)
(65)
(1)
(1)
(75)
(19)
(2)
(14)
(18)
(1)
(4)
(1)
(1)
(1)
(1)
(2)
(1)
(31)
(2)
(3)
(1)
(2)
(3)
(6)
(1)
(1)
(10)
(1)
(2)
(3)
(2)
(13)
(3)
(3)
(3)
(5)
(2)
(1)
(9)
(3)
(1)
(2)
(2)
(4)
(1)
(1)
(1)
(1)
(5)
(3)
(1)
(7)
(1)
(10)
(1)
(1)
(10)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(1)
(12)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(12)
(2)
(2)
(1)
(3)
(9)
(1)
(6)
(1)
(1)
(6)
(2)
(10)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(3)
(1)
(11)
(2)
(2)
(4)
(1)
(3)
(13)
(8)
(157)
(111)
(1)
(2)
(2)
(1)
(1)
(11)
(1)
(1)
(10)
(2)
(7)
(2)
(1)
(1)
(1)
(7)
(15)
(4)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(18)
(5)
(200)
(47)
(4)
(19)
(2)
(3)
(2)
(82)
(257)
(6)
(23)
(1)
(3)
(1)
(1)
(8)
(1)
(4)
(2)
(1)
(1)
(119)
(7)
(5)
(3)
(1)
(1)
(1)
(3)
(1)
(1)
(4)
(35)
(2)
(1)
(16)
(2)
(12)
(1)
(32)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(3)
(22)
(1)
(2)
(2)
(10)
(2)
(2)
(2)
(3)
(1)
(1)
(2)
(23)
(9)
(4)
(1)
(5)
(1)
(1)
(1)
(15)
(1)
(3)
(1)
(9)
(1)
(2)
(2)
(1)
(2)
(3)
(1)
(1)
(2)
(2)
(1)
(4)
(1)
(1)
(1)
(17)
(1)
(1)
(2)
(2)
(1)
(1)
(2)
(3)
(1)
(1)
(3)
(2)
(1)
(2)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(4)
(3)
(9)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(53)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(21)
(3)
(1)
(5)
(1)
(1)
(15)
(1)
(56)
(1)
(2)
(5)
(1)
(2)
(2)
(1)
(1)
(3)
(5)
(2)
(1)
(15)
(1)
(1)
(2)
(2)
(3)
(1)
(33)
(2)
(1)
(3)
(2)
(3)
(1)
(19)
(2)
(2)
(4)
(4)
(1)
(1)
(2)
(1)
(2)
(5)
(7)
(1)
(1)
(1)
(7)
(9)
(9)
(1)
(1)
(3)
(1)
(26)
(3)
(1)
(2)
(1)
(1)
(10)
(1)
(2)
(1)
(1)
(39)
(2)
(1)
(1)
(1)
(3)
(4)
(1)
(2)
(3)
(1)
(35)
(1)
(1)
(1)
(7)
(1)
(11)
(1)
(2)
(10)
(11)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(166)
(1)
(1)
(5)
(1)
(1)
(4)
(342)
(6)
(3)
(76)
(2)
(2)
(1)
(1)
(1)
(2)
(51)
(6)
(4)
(320)
(1)
(1)
(1)
(191)
(1)
(2)
(17)
(3)
(2)
(3)
(3)
(1)
(1)
(1)
(1)
(6)
(1)
(6)
(110)
(2)
(72)
(1)
(6)
(2)
(3)
(1)
(1)
(1)
(1)
(39)
(1)
(10)
(1)
(11)
(4)
(26)
(15)
(2)
(1)
(2)
(1)
(3)
(10)
(4)
(15)
(2)
(13)
(2)
(18)
(6)
(2)
(1)
(1)
(2)
(2)
(4)
(173)
(18)
(2)
(1)
(11)
(5)
(2)
(2)
(2)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(1)
(1)
(1)
(1)
(12)
(3)
(2)
(4)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(10)
(1)
(4)
(1)
(1)
(31)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(3)
(2)
(6)
(1)
(13)
(4)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(41)
(1)
(2)
(8)
(1)
(1)
(11)
(1)
(1)
(6)
(28)
(1)
(1)
(1)
(2)
(1)
(7)
(1)
(9)
(1)
(2)
(1)
(2)
(1)
(2)
(3)
(4)
(1)
(1)
(3)
(14)
(3)
(1)
(10)
(2)
(1)
(104)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(73)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(12)
(1)
(3)
(2)
(3)
(3)
(4)
(15)
(12)
(3)
(2)
(4)
(3)
(1)
(6)
(1)
(7)
(1)
(1)
(5)
(1)
(13)
(2)
(2)
(1)
(1)
(1)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(4)
(1)
(1)
(1)
(4)
(1)
(6)
(1)
(1)
(6)
(2)
(1)
(2)
(1)
(2)
(1)
(7)
(1)
(1)
(1)
(2)
(1)
(1)
(29)
(1)
(152)
(1)
(4)
(1)
(1)
(1)
(3)
(2)
(55)
(1)
(1)
(34)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(56)
(1)
(2)
(1)
(6)
(1)
(1)
(35)
(2)
(1)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(1)
(17)
(1)
(1)
(8)
(1)
(91)
(3)
(1)
(2)
(4)
(1)
(1)
(11)
(2)
(2)
(1)
(3)
(1)
(1)
(4)
(2)
(6)
(2)
(2)
(1)
(8)
(2)
(1)
(5)
(1)
(10)
(13)
(1)
(6)
(1)
(2)
(1)
(6)
(1)
(34)
(1)
(9)
(1)
(65)
(1)
(6)
(3)
(2)
(1)
(2)
(1)
(2)
(2)
(28)
(2)
(1)
(3)
(1)
(1)
(4)
(1)
(3)
(3)
(1)
(16)
(1)
(1)
(1)
(3)
(2)
(14)
(1)
(1)
(4)
(3)
(2)
(11)
(1)
(1)
(1)
(4)
(5)
(2)
(5)
(11)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(10)
(5)
(2)
(1)
(56)
(14)
(48)
(10)
(13)
(1)
(1)
(1)
(2)
(1)
(4)
(18)
(12)
(1)
(1)
(3)
(9)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(2)
(30)
(5)
(2)
(13)
(5)
(1)
(1)
(2)
(19)
(1)
(6)
(2)
(1)
(2)
(1)
(2)
(2)
(1)
(1)
(9)
(2)
(1)
(4)
(2)
(1)
(1)
(2)
(1)
(1)
(26)
(2)
(2)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(3)
(2)
(6)
(1)
(5)
(4)
(8)
(5)
(1)
(1)
(1)
(1)
(1)
(21)
(1)
(1)
(2)
(1)
(7)
(3)
(2)
(2)
(2)
(1)
(2)
(2)
(1)
(1)
(626)
(17)
(2)
(1)
(1)
(5)
(1)
(1)
(23)
(23)
(5)
(4)
(1)
(1)
(13)
(377)
(1)
(28)
(23)
(23)
(1)
(1)
(1)
(21)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(3)
(1)
(51)
(2)
(1)
(11)
(1)
(1)
(18)
(1)
(2)
(1)
(2)
(5)
(3)
(1)
(12)
(1)
(2)
(170)
(2)
(1)
(1)
(1)
(1)
(23)
(4)
(10)
(4)
(2)
(2)
(2)
(11)
(2)
(2)
(2)
(2)
(44)
(2)
(4)
0 of 1000
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(1)
(2)
(1)
(2)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(7)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(7)
(1)
(9)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(39)
(2)
(1)
(8)
(16)
(1)
(4)
(4)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(1)
(4)
(2)
(1)
(1)
(3)
(22)
(1)
(3)
(1)
(1)
(8)
(2)
(1)
(11)
(1)
(1)
(1)
(1)
(15)
(1)
(1)
(14)
(1)
(1)
(1)
(5)
(1)
(2)
(1)
(1)
(3)
(8)
(21)
(1)
(1)
(1)
(9)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(2)
(1)
(15)
(2)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(1)
(2)
(9)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(1)
(1)
(7)
(1)
(1)
(5)
(1)
(8)
(2)
(5)
(10)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(3)
(2)
(22)
(3)
(4)
(4)
(4)
(3)
(1)
(22)
(1)
(7)
(1)
(4)
(2)
(2)
(3)
(3)
(4)
(2)
(32)
(2)
(1)
(1)
(1)
(1)
(6)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(1)
(31)
(3)
(1)
(5)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(1)
(2)
(1)
(7)
(1)
(4)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(3)
(2)
(2)
(3)
(2)
(7)
(1)
(2)
(1)
(1)
(10)
(10)
(1)
(11)
(2)
(6)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(4)
(2)
(1)
(1)
(1)
(5)
(2)
(8)
(1)
(2)
(1)
(1)
(5)
(7)
(1)
(1)
(1)
(1)
(3)
(2)
(2)
(1)
(11)
(1)
(1)
(2)
(5)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(2)
(1)
(51)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(15)
(1)
(6)
(8)
(2)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(7)
(1)
(3)
(3)
(1)
(4)
(4)
(1)
(1)
(3)
(5)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(14)
(20)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(12)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(9)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(8)
(1)
(1)
(1)
(2)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(7)
(1)
(1)
(11)
(1)
(2)
(2)
(1)
(1)
(1)
(13)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(7)
(2)
(1)
(1)
(1)
(4)
(3)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(7)
(1)
(2)
(20)
(1)
(6)
(1)
(1)
(3)
(7)
(3)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(15)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(34)
(2)
(1)
(2)
(8)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(15)
(1)
(1)
(1)
(5)
(1)
(13)
(1)
(1)
(1)
(1)
(1)
(2)
(2)
(7)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(14)
(9)
(1)
(1)
(1)
(1)
(2)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(3)
(11)
(1)
(36)
(1)
(1)
(3)
(3)
(1)
(2)
(1)
(1)
(1)
(2)
(8)
(4)
(1)
(1)
(1)
(4)
(2)
(10)
(1)
(1)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(5)
(3)
(2)
(2)
(1)
(1)
(4)
(6)
(8)
(1)
(6)
(1)
(2)
(1)
(3)
(5)
(2)
(4)
(2)
(5)
(1)
(1)
(2)
(4)
(1)
(1)
(2)
(1)
(5)
(1)
(11)
(2)
(1)
(3)
(1)
(4)
(2)
(1)
(11)
(2)
(2)
(6)
(1)
(1)
(9)
(2)
(1)
(2)
(1)
(3)
(7)
(7)
(1)
(1)
(2)
(1)
(1)
(11)
(8)
(1)
(2)
(2)
(1)
(2)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(54)
(2)
(4)
(4)
(1)
(1)
(2)
(1)
(3)
(1)
(1)
(6)
(9)
(3)
(2)
(1)
(1)
(1)
(1)
(2)
(2)
(3)
(1)
(4)
(1)
(3)
(1)
(1)
(6)
(3)
(2)
(2)
(1)
(1)
(1)
(4)
(7)
(2)
(3)
(1)
(8)
(1)
(1)
(25)
(1)
(1)
(10)
(16)
(1)
(2)
(1)
(1)
(2)
(1)
(1)
(6)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(14)
(4)
(3)
(2)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(18)
(1)
(2)
(1)
(1)
(7)
(1)
(2)
(10)
(1)
(1)
(1)
(1)
(1)
(30)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(3)
(2)
(1)
(1)
(3)
(1)
(2)
(1)
(19)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(8)
(1)
(1)
(30)
(5)
(1)
(1)
(11)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(2)
(8)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(4)
(2)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(8)
(2)
(1)
(1)
(2)
(45)
(1)
(1)
(7)
(1)
(1)
(3)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(10)
(1)
(1)
(1)
(10)
(1)
(1)
(13)
(1)
(8)
(7)
(2)
(2)
(1)
(8)
(8)
(2)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(7)
(8)
(2)
(1)
(32)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(10)
(1)
(1)
(2)
(1)
(2)
(1)
(3)
(5)
(4)
(1)
(2)
(1)
(2)
(1)
(1)
(9)
(1)
(1)
(2)
(10)
(2)
(1)
(1)
(1)
(2)
(1)
(6)
(1)
(1)
(2)
(1)
(4)
(2)
(2)
(26)
(1)
(1)
(24)
(1)
(1)
(1)
(1)
(1)
(3)
(3)
(1)
(1)
(2)
(4)
(5)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(5)
(4)
(2)
(2)
(1)
(1)
(11)
(3)
(1)
(4)
(1)
(1)
(5)
(1)
(2)
(9)
(1)
(1)
(6)
(1)
(2)
(1)
(3)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(2)
(4)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
0 of 990
(2)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(5)
(24)
(3)
(4)
(6)
(1)
(16)
(21)
(9)
(1)
(1)
(1)
(1)
(6)
(3)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(3)
(9)
(1)
(3)
(6)
(1)
(1)
(2)
(14)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(29)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(51)
(115)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(6)
(1)
(1)
(2)
(2)
(9)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(5)
(1)
(11)
(1)
(2)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(1)
(4)
(2)
(1)
(1)
(1)
(6)
(1)
(1)
(8)
(1)
(2)
(7)
(5)
(1)
(1)
(5)
(2)
(6)
(1)
(1)
(1)
(12)
(1)
(9)
(2)
(1)
(5)
(3)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(4)
(3)
(4)
(1)
(16)
(11)
(1)
(8)
(6)
(1)
(3)
(1)
(5)
(1)
(3)
(25)
(3)
(8)
(1)
(1)
(1)
(30)
(4)
(6)
(1)
(62)
(3)
(1)
(1)
(2)
(31)
(2)
(13)
(2)
(1)
(11)
(7)
(5)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(9)
(1)
(10)
(14)
(2)
(10)
(1)
(90)
(1)
(1)
(1)
(1)
(1)
(1)
(7)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(47)
(4)
(3)
(2)
(66)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(83)
(1)
(1)
(1)
(2)
(53)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(3)
(2)
(6)
(9)
(1)
(10)
(1)
(1)
(2)
(3)
(6)
(2)
(1)
(5)
(4)
(1)
(3)
(2)
(1)
(1)
(13)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(1)
(22)
(3)
(7)
(1)
(1)
(1)
(1)
(1)
(7)
(2)
(2)
(4)
(1)
(1)
(1)
(4)
(9)
(1)
(2)
(1)
(1)
(1)
(3)
(1)
(2)
(3)
(3)
(1)
(2)
(10)
(1)
(6)
(1)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(7)
(1)
(1)
(1)
(1)
(14)
(1)
(11)
(550)
(1)
(1)
(1)
(6)
(1)
(3)
(1)
(4)
(10)
(1)
(15)
(11)
(14)
(1)
(4)
(4)
(1)
(2)
(2)
(5)
(1)
(4)
(163)
(1)
(5)
(1)
(3)
(7)
(3)
(1)
(33)
(2)
(14)
(3)
(3)
(9)
(2)
(1)
(10)
(1)
(2)
(30)
(6)
(1)
(4)
(4)
(5)
(2)
(7)
(1)
(6)
(2)
(1)
(19)
(15)
(1)
(1)
(9)
(5)
(1)
(2)
(2)
(18)
(3)
(5)
(46)
(2)
(1)
(2)
(3)
(2)
(1)
(3)
(4)
(1)
(5)
(1)
(1)
(1)
(4)
(3)
(1)
(1)
(7)
(2)
(2)
(3)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(3)
(7)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(10)
(3)
(2)
(3)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(11)
(1)
(1)
(1)
(3)
(1)
(2)
(1)
0 of 476
(1)
(74)
(1)
(1)
(1623)
(33)
(8)
(24)
(1)
(1)
(1)
(200)
(7)
(75)
(1293)
(1)
(1)
(1)
(2)
(68)
(1)
(1)
(1)
0 of 23
(1)
0 of 1
Showing 141 - 160 of 2197 results
  • Bridge Access Program Ensuring nocost timely access to the 20232024 COVID19 vaccines for adults
    Bridge Access Program : Ensuring no-cost, timely access to the 2023-2024 COVID-19 vaccines for adults
    Twentyman, Evelyn
    September 12, 2023 | ACIP: Coronavirus Disease 2019 (COVID-19)
    13-COVID-Twentyman-508.pdf
    Public Domain
  • Safety and Immunogenicity of Moderna COVID19 Vaccine 20232024 Formula Monovalent XBB15 Variant Vaccine
    Safety and Immunogenicity of Moderna COVID-19 Vaccine (2023-2024 Formula): Monovalent XBB.1.5 Variant Vaccine
    Priddy, Frances
    September 12, 2023 | ACIP meeting COVID-19 Vaccines
    08-COVID-Priddy-508.pdf
    Public Domain
  • Final Agenda MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES ACIP September 12 2023
    Final - Agenda : MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP), September 12, 2023
    United States. Advisory Committee on Immunization Practices.
    September 11, 2023 | ACIP: Meeting Agenda, Minutes, etc.
    Publication date from document properties.agenda-2023-09-12-508.pdf
    Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports September 8 2023 Vol 72 No RR3
    Morbidity and Mortality Weekly Report: Recommendations and Reports, September 8, 2023 / Vol. 72 / No. RR-3
    Kobayashi, Miwako ;
    Pilishvili, Tamara
    09/08/2023 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report compiles and summarizes all published recommendations from CDC’s Advisory Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults aged ≥19 years in the United States. This report also includes updated and new clinical guidance for implementation from CDCBefore 2021, ACIP recommended 23-valent pneumococcal p ...
    Supporting Files Public Domain
  • Morbidity and Mortality Weekly Report Recommendations and Reports August 25 2023 Vol 72 No RR2
    Morbidity and Mortality Weekly Report: Recommendations and Reports, August 25, 2023 / Vol. 72 / No. RR-2
    Grohskopf, Lisa A. ;
    Blanton, Lenee H.
    August 25, 2023 | Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
    This report updates the 2022–23 recommendations of the Advisory Committee on Immunization Practices (ACIP) concerning the use of seasonal influenza vaccines in the United States (MMWR Recomm Rep 2022;71[No. RR-1]:1–28). Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. All seasonal ...
    Supporting Files Public Domain
  • Prevention and control of seasonal influenza with vaccines recommendations of the Advisory Committee on Immunization Practices ACIP United States 202324 summary of recommendations
    Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2023-24 : summary of recommendations
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office.  ...
    8-23-2023
    cdc:132249For additional information: MMWR Recomm Rep 2023;72(No. RR-2), at https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html.This document is available in HTML format at https://www.cdc.gov/flu/professionals/acip/summary/summary-recommendations.htm.acip-2023-24-Summary-Flu-Vaccine-Recommendations.pdf
    Supporting Files Public Domain
  • Resumen Prevencin y control de la influenza estacional con vacunas recomendaciones del Comit Asesor sobre Prcticas de Vacunacin ACIP Estados Unidos 202324
    Resumen: "Prevención y control de la influenza estacional con vacunas: recomendaciones del Comité Asesor sobre Prácticas de Vacunación (ACIP), Estados Unidos, 2023-24"
    National Center for Immunization and Respiratory Diseases (U.S.)
    23 de agosto del 2023
    Summary: ‘Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2023-24’ [Spanish]
    Supporting Files Multi-Language Public Domain
  • Summary Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices ACIPUnited States 202324
    Summary: ‘Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2023-24’
    National Center for Immunization and Respiratory Diseases (U.S.)
    August 23, 2023
    cdc:132249
    Supporting Files Multi-Language Public Domain
  • ACIP Recommendations
    ACIP Recommendations
    National Center for Immunization and Respiratory Diseases (U.S.)  ...
    August 4, 2023
    The ACIP develops recommendations on how to use vaccines to control disease in the United States.The Committee’s recommendations are forwarded to CDC’s Director and once adopted become official CDC policy. These recommendations are then published in CDC’s Morbidity and Mortality Weekly Report (MMWR).ACIP approved the following recommendations by ma ...
    Supporting Files Public Domain
  • Evidence to Recommendations Framework Nirsevimab Updates
    Evidence to Recommendations Framework : Nirsevimab Updates
    Jones, Jefferson
    August 3, 2023 | ACIP: Respiratory Syncytial Virus (RSV)
    02-RSV-jones-508.pdf
    Public Domain
  • Nirsevimab
    Nirsevimab
    Jones, Jefferson
    August 3, 2023 | ACIP: Respiratory Syncytial Virus (RSV)
    04-RSV-Jones-508.pdf
    Public Domain
  • Nirsevimab Implementation Considerations
    Nirsevimab: Implementation Considerations
    Peacock, Georgina
    August 3, 2023 | ACIP: Respiratory Syncytial Virus (RSV)
    03-RSV-Peacock-508.pdf
    Public Domain
  • MaternalPediatric Respiratory Syncytial Virus RSV Work Group
    Maternal/Pediatric Respiratory Syncytial Virus (RSV) Work Group
    Long, Sarah S.
    August 3, 2023 | ACIP: Respiratory Syncytial Virus (RSV)
    01-RSV-Long-508.pdf
    Public Domain
  • Agenda Meeting of the Advisory Committee on Immunization Practices August 3 2023 Final August 2 2023
    [Agenda] Meeting of the Advisory Committee on Immunization Practices, August 3, 2023 : Final- August 2, 2023
    United States. Advisory Committee on Immunization Practices.
    August 2, 2023 | ACIP: Meeting Agenda, Minutes, etc.
    agenda-2023-08-03-508.pdf
    Public Domain
  • Agenda Meeting of the Advisory Committee on Immunization Practices August 3 2023 DRAFT July 17 2023
    [Agenda] Meeting of the Advisory Committee on Immunization Practices, August 3, 2023 : DRAFT - July 17, 2023
    United States. Advisory Committee on Immunization Practices.
    July 17, 2023 | ACIP: Meeting Agenda, Minutes, etc.
    Publication date from document properties.agenda-2023-08-03-508.pdf
    Public Domain
  • Evidence to Recommendations Framework Pfizers MenABCWY vaccine
    Evidence to Recommendations Framework : Pfizer’s MenABCWY vaccine
    Crowe, Sam
    June 23, 2023 | ACIP: Menigococcal
    03-Mening-Crowe-508.pdf
    Public Domain
  • The Costeffectiveness of a potential pentavalent meningococcal conjugate vaccine Men ABCWY versus the current Men ACWY and Men B vaccines for US adolescents
    The Cost-effectiveness of a potential pentavalent meningococcal conjugate vaccine (Men ABCWY) versus the current Men ACWY and Men B vaccines for US adolescents
    Ortega-Sanchez, Ismael R.
    June 23, 2023 | ACIP: Menigococcal
    02-Mening-Ortega-Sanchez-508.pdf
    Public Domain
  • Use of JYNNEOS during mpox outbreaks clinical guidance
    Use of JYNNEOS during mpox outbreaks : clinical guidance
    Rao, Agam
    June 23, 2023 | ACIP: Mpox
    03-mpox-Rao-508.pdf
    Public Domain
  • The Childhood immunization schedule and safety studies in the Vaccine Safety Datalink
    The Childhood immunization schedule and safety : studies in the Vaccine Safety Datalink
    Daley, Matthew F.
    June 23, 2023 | ACIP: Vaccine Safety
    02-VaxSafety-Daley-508.pdf
    Public Domain
  • Considerations for longterm protection against mpox
    Considerations for long-term protection against mpox
    Rao, Agam
    June 23, 2023 | ACIP: Mpox
    04-mpox-Rao-508.pdf
    Public Domain
141 - 160 / 2197